Olga Venditti
St. Salvatore Hospital
L'aquila, Italy
L'aquila, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Journal: Frontiers in oncology
Published: May 19, 2021
Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.
Journal: Clinical colorectal cancer
Published: March 02, 2021
A case of segmental hepatic necrosis complicating oxaliplatin and capecitabine chemotherapy A case report and review of the literature.
Journal: Annali italiani di chirurgia
Published: October 06, 2020
Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study.
Journal: Journal of gastrointestinal cancer
Published: July 07, 2020
Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study.
Journal: Cancers
Published: April 25, 2020
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?
Journal: Journal of bone oncology
Published: March 31, 2020
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab.
Journal: Expert opinion on biological therapy
Published: February 04, 2020
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
Journal: Scientific reports
Published: September 25, 2019
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.
Journal: Journal of cancer research and clinical oncology
Published: April 28, 2019
Predictive Ability for Disease-Free Survival of the GRade, Age, Nodes, and Tumor (GRANT) Score in Patients with Resected Renal Cell Carcinoma.
Journal: Current urology
Published: April 01, 2019
Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation.
Journal: Bioengineering (Basel, Switzerland)
Published: December 18, 2018
Last Updated: 09/26/2026